These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36989335)

  • 1. Treatment response to supplemental nutrients for ADHD is independent of diet quality: the MADDY Study RCT.
    Robinette LM; Hatsu IE; Johnstone JM; Bruton AM; Leung BMY; Arnold LE
    Nutr Neurosci; 2024 Apr; 27(4):319-328. PubMed ID: 36989335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension.
    Leung BMY; Srikanth P; Robinette L; Bruton AM; Tost G; Hatsu I; Arnold LE; Johnstone JM
    Eur Child Adolesc Psychiatry; 2024 May; 33(5):1355-1367. PubMed ID: 37291464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial.
    Johnstone JM; Hatsu I; Tost G; Srikanth P; Eiterman LP; Bruton AM; Ast HK; Robinette LM; Stern MM; Millington EG; Gracious BL; Hughes AJ; Leung BMY; Arnold LE
    J Am Acad Child Adolesc Psychiatry; 2022 May; 61(5):647-661. PubMed ID: 34303786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems most concerning to parents of children with ADHD and emotional dysregulation in a randomized controlled trial of multinutrients: MADDY secondary analysis.
    Tost G; Srikanth P; Bruton A; Hatsu IE; Leung BM; Ast HK; Eiterman LP; Robinette LM; Williams C; Gracious B; Eugene Arnold L; Johnstone JM
    Eur Child Adolesc Psychiatry; 2024 May; ():. PubMed ID: 38819662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating mineral biomarkers as mediators and moderators of behavioural improvements in a randomised controlled trial of multinutrients for children with attention-deficit/hyperactivity disorder.
    Robinette LM; Johnstone JM; Srikanth P; Bruton AM; Ralle M; Ast HK; Bradley RD; Leung B; Arnold LE; Hatsu IE
    Br J Nutr; 2024 May; ():1-15. PubMed ID: 38818718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fruit and vegetable intake is inversely associated with severity of inattention in a pediatric population with ADHD symptoms: the MADDY Study.
    Robinette LM; Hatsu IE; Johnstone JM; Tost G; Bruton AM; Leung BMY; Odei JB; Orchard T; Gracious BL; Arnold LE
    Nutr Neurosci; 2023 Jun; 26(6):572-581. PubMed ID: 35535573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial.
    Rucklidge JJ; Eggleston MJF; Johnstone JM; Darling K; Frampton CM
    J Child Psychol Psychiatry; 2018 Mar; 59(3):232-246. PubMed ID: 28967099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric adverse event rating scale: a measure of safety or efficacy? Novel analysis from the MADDY study.
    Leung BMY; Srikanth P; Gracious B; Hatsu IE; Tost G; Conrad V; Johnstone JM; Arnold LE
    Curr Med Res Opin; 2022 Sep; 38(9):1595-1602. PubMed ID: 35770861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderators of treatment response in adults with ADHD treated with a vitamin-mineral supplement.
    Rucklidge JJ; Johnstone J; Gorman B; Boggis A; Frampton CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():163-71. PubMed ID: 24374068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multinutrients for the Treatment of Psychiatric Symptoms in Clinical Samples: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Johnstone JM; Hughes A; Goldenberg JZ; Romijn AR; Rucklidge JJ
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33158241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we predict treatment response in children with ADHD to a vitamin-mineral supplement? An investigation into pre-treatment nutrient serum levels, MTHFR status, clinical correlates and demographic variables.
    Rucklidge JJ; Eggleston MJF; Darling KA; Stevens AJ; Kennedy MA; Frampton CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():181-192. PubMed ID: 30217770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study.
    Gordon HA; Rucklidge JJ; Blampied NM; Johnstone JM
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):783-98. PubMed ID: 26682999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: The Micronutrients for ADHD in Youth (MADDY) study.
    Johnstone JM; Leung B; Gracious B; Perez L; Tost G; Savoy A; Hatsu I; Hughes A; Bruton A; Arnold LE
    Contemp Clin Trials Commun; 2019 Dec; 16():100478. PubMed ID: 31763491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial.
    Findling RL; Adler LA; Spencer TJ; Goldman R; Hopkins SC; Koblan KS; Kent J; Hsu J; Loebel A
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):80-89. PubMed ID: 30694697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
    Stein MA; Sikirica V; Weiss MD; Robertson B; Lyne A; Newcorn JH
    CNS Drugs; 2015 Nov; 29(11):953-62. PubMed ID: 26547425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral-Vitamin Treatment Associated with Remission in Attention-Deficit/Hyperactivity Disorder Symptoms and Related Problems: 1-Year Naturalistic Outcomes of a 10-Week Randomized Placebo-Controlled Trial.
    Darling KA; Eggleston MJF; Retallick-Brown H; Rucklidge JJ
    J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):688-704. PubMed ID: 31343273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.